Multiple sclerosis--biochemical-immunologic and therapeutic aspects
Maciejek, Z.
Wiadomosci Lekarskie 43(5-6): 232-239
1990
ISSN/ISBN: 0043-5147 PMID: 2195779 Document Number: 355933
Document emailed within 1 workday
Related Documents
Mal'tsev, D.V. 2014: Unresolved problems and the prospects for research in area of the multiple sclerosis: virologic, immunologic and therapeutic aspects Likars'ka Sprava 2014(5-6): 3-19Taylor, R.S. 1998: Immunologic aspects of multiple sclerosis Physical Medicine and Rehabilitation Clinics of North America 9(3): 525
Gonsette, R.E. 1982: Therapeutic aspects of multiple sclerosis Bulletin de la Societe Belge d'Ophtalmologie 199-200: 275-280
Prokof'ev, V.F.; Konenkov, V.I.; Gribacheva, I.A.; Voronova, I.A.; Doronin, B.M. 1989: Clinico-immunologic parallels in multiple sclerosis Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 89(2): 31-34
Mavra, M.; Vranjesević, D.; Radosavljević, B. 1984: Immunologic profile of cerebrospinal fluid in multiple sclerosis in childhood Srpski Arhiv Za Celokupno Lekarstvo 112(2): 205-214
Hauser, S.L.; Fosburg, M.; Kevy, S.V.; Weiner, H.L. 1984: Lymphocytapheresis in chronic progressive multiple sclerosis: immunologic and clinical effects Neurology 34(7): 922-926
Cazzullo, C.L.; Montanini, R.; Ghezzi, A.; Zaffaroni, M.; Giussani, D.; Loner, R.; Caputo, D.; Marforio, S.; Zibetti, A. 1984: Clinical, immunologic and electrophysiologic correlations in evaluating multiple sclerosis in relation to its development Minerva Medica 75(43): 2585-2589
Kastrukoff, L.F.; Oger, J.J.; Tourtellotte, W.W.; Sacks, S.L.; Berkowitz, J.; Paty, D.W. 1991: Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation Neurology 41(12): 1936-1941
Mel'nichuk, P.V.; Rogovina, N.I.; Khokhlov, A.P. 1980: Changes of clinico-biochemical indicators in multiple sclerosis treated with hormones and antioxidants Sovetskaia Meditsina 1980(6): 55-57
Bartosik-Psujek, H.; Stelmasiak, Z. 2001: Biochemical markers of damage of the central nervous system in multiple sclerosis Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 56: 389-392
Zavalishin, I.A.; Khokhlov, A.P.; Larskiĭ, E.G.; Seĭfulla, R.D.; Roĭkhel', V.M. 1988: Biochemical aspects of the pathogenesis of amyotrophic lateral sclerosis Vestnik Akademii Meditsinskikh Nauk SSSR 12: 49-56
Chofflon, M. 2003: Multiple sclerosis: current therapeutic strategies Revue Medicale de la Suisse Romande 123(1): 27-32
Abramsky, O.; Lisak, R.P. 1978: Immunobiological aspects of multiple sclerosis Harefuah 94(9): 283-286
Taylor, A.; Taylor, R.S. 1998: Neuropsychologic aspects of multiple sclerosis Physical Medicine and Rehabilitation Clinics of North America 9(3): 643
Matcău, L.; Sofletea, A.; Minciu, E.; Marcovici, H.; Creţu, M. 1968: Clinical aspects of multiple sclerosis Neurologia Psihiatria Neurochirurgia 13(6): 493-502
Edan, G.; Coustans, M. 2000: Is immunosuppression a future therapeutic strategy for multiple sclerosis? Pathologie-Biologie 48(2): 114-120
Payk, T.R. 1973: Therapeutic problems in disseminated encephalomyelitis (multiple sclerosis) Therapie der Gegenwart 112(3): 349-350
Edan, G. 1998: New therapeutic strategies for multiple sclerosis: unanswered questions Revue Neurologique (Paris) 154(12): 813-815
Grimaud, J.; Pageot, N.; Rovaris, M. 2001: Parallels between clinical aspects and MRI in multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 1): 884-890
Rumbach, L. 2001: Therapeutic indications targeting etiology of progressive multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 2): 1001-1007